Sinopros Corporation Limited

Sinopros Corporation Limited

HHKEX:727
0.44
HKD
0.00
(0.00%)
890.29MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.07
0.03
0.02
0.07
0.03
0.03
0.07
0.07
0.09
- -
0.87
0.09
0.18
- -
Basic EPS, GAAP
-0.51
1.37
1.09
0.49
0.6
0.02
0.05
-0.53
-3.64
-5.25
-0.6
0.01
-0.17
- -
Free Cash Flow per Basic Share
-0.32
-4.57
2.86
-0.21
-0.63
-1.52
-0.7
-0.02
-0.1
-1.33
1.29
-0.25
-1.73
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-1.48
5.06
7.29
7.3
10.83
10.16
9.53
9.79
6.58
0.8
0.59
1.01
0.76
0.76
Tangible Book Value per Share
-1.48
4.63
7.29
7.3
10.83
10.16
9.53
9.79
6.58
0.8
0.59
1.01
0.76
0.76
Basic Weighted Avg Shares
89
113
158
166
181
200
200
200
200
204
210
1,272
415
473
Sales/Revenue/Turnover
6
4
4
12
5
5
15
14
17
- -
183
111
74
- -
Operating Margin (%)
-559.76
-848.24
-677.63
-263.42
-457.98
-620.85
-122.66
-110.91
-161.36
- -
16.41
15.99
-11.6
- -
Depreciation Expense
2
1
1
1
1
1
9
8
7
4
2
1
7
- -
Net Income, GAAP
-45
155
172
81
109
4
9
-105
-726
-1,069
-127
16
-71
- -
Effective Tax Rate (%)
- -
3.98
21.25
34.03
0.82
74.32
59.94
- -
- -
- -
- -
31.22
- -
- -
Profit Margin (%)
-757.2
4,269.47
4,902.28
676.48
2,176.5
70.58
62.89
-759
-4,150.93
- -
-69.11
14.48
-95.17
- -
Working Capital
-225
115
97
65
522
870
226
91
-7
5
-31
1,007
1,634
1,634
LT Debt
- -
- -
- -
- -
160
598
41
10
7
2
- -
826
877
877
Total Equity
-40
766
1,214
1,216
2,162
2,028
1,902
1,953
1,312
164
121
375
960
960
Return on Invested Capital (%)
- -
19.14
15.8
6.95
6.17
0.12
0.36
- -
- -
- -
- -
1.48
- -
- -
Return on Capital (%)
- -
19.24
15.89
7.11
6.25
0.16
0.41
- -
- -
- -
- -
1.52
- -
- -
Return on Common Equity (%)
- -
- -
17.4
6.7
6.44
0.18
0.48
-5.46
-44.48
-144.73
-88.67
6.51
-10.57
- -

Capital Structure

HKD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
1
- -
2
LT Borrowings
820
836
869
LT Finance Leases
6
6
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
370
370
1,272
Market Capitalization
327
394
890

Working Capital

HKD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
1,315
1,195
1,959
Cash, Cash Equivalents & STI
111
14
12
Accounts Receivable, Net
- -
- -
6
Inventories
754
762
1,493
Total Current Liabilities
308
297
324
Payables & Accruals
- -
- -
- -
ST Debt
1
- -
2
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
28.76%
43.85%
156.31%
Free Cash Flow
147.34%
267.97%
127.07%
Net Income, GAAP
-129.1%
-20.13%
-537.19%
Sales/Revenue/Turnover
- -
- -
-33.47%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
183
2025
- -
- -
111
2026
- -
- -
74

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.6
2025
- -
- -
0.01
2026
- -
- -
-0.17

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Yu Chun Fai
Full Time Employees
92
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
China Resources Building Hong Kong Hong Kong
IPO Date
Sep 29, 2005
Business
Crown International Corporation Limited (0727.HK) is an investment holding company principally engaged in property investment and development in the People's Republic of China. The company operates through five main segments: Property Investment, involving commercial buildings, hotels, and residential and commercial complexes; Property Development, focused on developing and selling properties; Hotel Operations, encompassing hotel rentals, investments, and food and beverage services; Trading and Developing of Premium White Spirit, including the trade, development, and sale of premium baijiu products; and Comprehensive Healthcare Planning and Management Services, providing healthcare planning, management, financial consultancy, and setup services for healthcare businesses, alongside sales of healthcare products. It primarily serves customers in China, with additional operations in hotel and beverage sectors targeting domestic markets. Incorporated in 1993 and headquartered in Wan Chai, Hong Kong, the company, formerly known as VXL Capital Limited, changed its name in August 2014. In December 2024, a wholly-owned subsidiary entered a memorandum of understanding for the potential acquisition of 100% equity interest in Sichuan Tianfu Jinpenji Wine Industry Group Co., Ltd., a PRC-based baijiu producer, marking a strategic expansion in the premium white spirit segment.